Cargando…
Nanoliposomes for Controlled Release of Cannabinodiol at Relevant Gastrointestinal Conditions
[Image: see text] Cannabidiol (CBD) has significant therapeutic potential; nevertheless, its advance as an effective drug by the pharmaceutical business is hindered by its inherent characteristics, such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. This researc...
Autores principales: | Zapata, Karol, Rosales, Stephania, Rios, As, Rojano, Benjamin, Toro-Mendoza, Jhoan, Riazi, Masoud, Franco, Camilo A., Cortés, Farid B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666248/ https://www.ncbi.nlm.nih.gov/pubmed/38027358 http://dx.doi.org/10.1021/acsomega.3c05371 |
Ejemplares similares
-
Dual-Purpose Materials Based on Carbon Xerogel Microspheres (CXMs) for Delayed Release of Cannabidiol (CBD) and Subsequent Aflatoxin Removal
por: Cortés, Farid B., et al.
Publicado: (2019) -
Armored
Droplets as Soft Nanocarriers for Encapsulation
and Release under Flow Conditions
por: Sicard, François, et al.
Publicado: (2021) -
Immobilization of P. stutzeri on Activated Carbons for Degradation of Hydrocarbons from Oil-in-Saltwater Emulsions
por: Zapata Acosta, Karol, et al.
Publicado: (2019) -
ACS Omega: Writing a New Chapter
in a One-Hundred-Year-Old Partnership between Latin America and the
American Chemical Society
por: Toro-Mendoza, Jhoan
Publicado: (2023) -
Designing Nanoliposome-in-Natural Hydrogel Hybrid System for Controllable Release of Essential Oil in Gastrointestinal Tract: A Novel Vehicle
por: Basyigit, Bulent
Publicado: (2023)